Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
cHGV8w8DgzPJnbAe
Listen
